Kura Oncology, Inc. Quarterly Return On Equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kura Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q3 2024.
  • Kura Oncology, Inc. Return On Equity for the quarter ending September 30, 2024 was -44.1 %, a 31.5% decline year-over-year.
  • Kura Oncology, Inc. annual Return On Equity for 2023 was -36.3 %, a 17.9% decline from 2022.
  • Kura Oncology, Inc. annual Return On Equity for 2022 was -30.8 %, a 28.8% decline from 2021.
  • Kura Oncology, Inc. annual Return On Equity for 2021 was -23.9 %, a 3.86% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -44.1 -10.6 -31.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -40.4 -7.42 -22.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.5 -4.88 -15% Jan 1, 2024 Mar 31, 2024
Q4 2023 -36.3 -5.52 -17.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -33.5 -4.28 -14.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -33 -5.88 -21.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.6 -7.15 -28.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.8 -6.89 -28.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29.3 -7.61 -35.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -27.1 -4.96 -22.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -25.5 -3.34 -15.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -23.9 +0.96 +3.86% Oct 1, 2021 Dec 31, 2021
Q3 2021 -21.7 +9.31 +30.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -22.2 +8.08 +26.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.2 +8.18 +27% Jan 1, 2021 Mar 31, 2021
Q4 2020 -24.8 +4.92 +16.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -31 +0.09 +0.29% Jul 1, 2020 Sep 30, 2020
Q2 2020 -30.3 +2.54 +7.75% Apr 1, 2020 Jun 30, 2020
Q1 2020 -30.3 +9.69 +24.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -29.8 +12.5 +29.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -31.1 +13.8 +30.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -32.8 +15.9 +32.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -40 +10.4 +20.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -42.2 +11.7 +21.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -44.8 +8.57 +16% Jul 1, 2018 Sep 30, 2018
Q2 2018 -48.7 +6.6 +11.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -50.4 -3.09 -6.54% Jan 1, 2018 Mar 31, 2018
Q4 2017 -53.9 -12.6 -30.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -53.4 -16.8 -46% Jul 1, 2017 Sep 30, 2017
Q2 2017 -55.3 -16.4 -42.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -47.3 -5.87 -14.2% Jan 1, 2017 Mar 31, 2017
Q4 2016 -41.3 +1.32 +3.09% Oct 1, 2016 Dec 31, 2016
Q3 2016 -36.6 +26.1 +41.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -38.9 +23.1 +37.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -41.4 +30.8 +42.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -42.7 -427 -111% Oct 1, 2015 Dec 31, 2015
Q3 2015 -62.6 -84.3 Jul 1, 2015 Sep 30, 2015
Q2 2015 -62 -84.6 Apr 1, 2015 Jun 30, 2015
Q1 2015 -72.2 -96.1 Jan 1, 2015 Mar 31, 2015
Q4 2014 384 +359 +1402% Aug 22, 2014 Dec 31, 2014
Q3 2014 21.6* -5.61 Jul 1, 2014 Sep 30, 2014
Q2 2014 22.6* +22.5 Apr 1, 2014 Jun 30, 2014
Q1 2014 23.9* +23.8 Jan 1, 2014 Mar 31, 2014
Q4 2013 25.6 +25.5 +55811% Oct 1, 2013 Dec 31, 2013
Q3 2013 27.2* +27.2 Jul 1, 2013 Sep 30, 2013
Q2 2013 0.13* +0.08 Apr 1, 2013 Jun 30, 2013
Q1 2013 0.07* -0.01 Jan 1, 2013 Mar 31, 2013
Q4 2012 0.05 -0.03 -37.8% Oct 1, 2012 Dec 31, 2012
Q3 2012 0.03* Jul 1, 2012 Sep 30, 2012
Q2 2012 0.05* Apr 1, 2012 Jun 30, 2012
Q1 2012 0.08* Jan 1, 2012 Mar 31, 2012
Q4 2011 0.08 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.